Cardiex Ltd Buy Hold or Sell Recommendation

AMDHF -- USA Stock  

USD 0.025  0.00  0.00%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Cardiex Ltd is 'Hold'. Macroaxis provides Cardiex Ltd buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AMDHF positions. The advice algorithm takes into account all of Cardiex Ltd available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AMDHF buy-and-hold prospective. Check also Cardiex Ltd Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Cardiex LtdBuy Cardiex Ltd
Cautious Hold

Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon Cardiex Ltd has a mean deviation of 2.9, semi deviation of 0.0, standard deviation of 9.94, variance of 98.77, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Cardiex Ltd. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Cardiex Ltd is not overpriced, please confirm all Cardiex Ltd fundamentals including its Cash Flow from Operations, Retained Earnings and the relationship between Cash and Equivalents and Beta . As Cardiex Ltd appears to be a penny stock we also recommend to validate its Price to Book numbers.

Cardiex Ltd Trading Alerts and Improvement Suggestions

Cardiex Ltd generates negative expected return over the last 30 days
Cardiex Ltd has some characteristics of a very speculative penny stock
Cardiex Ltd has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 3.29M. Net Loss for the year was (2.64M) with profit before overhead, payroll, taxes, and interest of 3.88M.
ATCOR MEDICAL HOL has accumulated about 535.62K in cash with (1.49M) of positive cash flow from operations.

Cardiex Ltd Returns Distribution Density

Mean Return1.48Value At Risk0.00
Potential Upside0.00Standard Deviation9.94
 Return Density 
      Distribution 

Cardiex Ltd Greeks

α
Alpha over DOW
=1.40
β
Beta against DOW=2.36
σ
Overall volatility
=0.00
Ir
Information ratio =0.14

Cardiex Ltd Volatility Alert

Cardiex Ltd is displaying above average volatility of 9.94 over selected time horizon. Investors should scrutinize Cardiex Ltd independently to make sure intended market timing strategies are aligned with expectations about Cardiex Ltd volatility. Cardiex Ltd is a penny stock. Although Cardiex Ltd may be in fact a good investment, many penny stocks are subject to artificial stock hype. Make sure you completely understand upside potential and downside risk of investing in Cardiex Ltd. We encourage investors to look for the signals such us message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare Cardiex Ltd to competition

Cardiex Ltd Fundamental Vs Peers

FundamentalsCardiex LtdPeer Average
Return On Equity(51.60)% (0.31)%
Return On Asset(20.30)% (0.14)%
Profit Margin(62.87)% (1.27)%
Current Valuation16.26M16.62B
Shares Outstanding532.82M571.82M
Price to Earning(1.47)X28.72X
Price to Book3.75X9.51X
Price to Sales4.20X11.42X
Revenue3.29M9.43B
Gross Profit3.88M27.38B
EBITDA(2.07M)3.9B
Net Income(2.64M)570.98M
Cash and Equivalents535.62K2.7B
Debt to Equity48.20% 48.70%
Current Ratio1.38X2.16X
Cash Flow from Operations(1.49M)971.22M
Earnings Per Share(0.011)X3.12X
Number of Employees818.84K
Beta1.35-0.15
Market Capitalization16.78M19.03B
Total Asset5M29.47B
Retained Earnings(38M)9.33B
Working Capital3M1.48B
Current Asset4M9.34B
Current Liabilities1000K7.9B
Z Score-9.88.72
Search macroaxis.com